Problems › Should We Enter a New Market? › Education & Training Providers
Enrolment targets are the easy half. Whether existing completion rates and instructor utilisation transfer decides the outcome. What makes this harder for education and training providers is structural: to reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda. Any credible answer therefore has to hold 14.4 % and 71 % in the same view, which is exactly where most internal analysis stops because the two live in different systems.
Enrolment targets are the easy half. Whether existing completion rates and instructor utilisation transfer decides the outcome. What makes this harder for education and training providers is structural: to reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda. Any credible answer therefore has to hold 14.4 % and 71 % in the same view, which is exactly where most internal analysis stops because the two live in different systems.
Potential new cohorts get sized by enrolment yield and total headcount, both of which can be modelled, yet neither forecasts whether the 312 USD cost per learner acquired will be offset by the same completion rate achieved in current blended cohorts or whether fresh instructor capacity must be added from scratch.
A market segment can show strong enrolment growth and still destroy value once incremental support costs are applied; the reverse holds when an operator already runs high-utilisation cohorts whose completion rate and cost per learner acquired carry over without rebuilding the delivery model.
A pre-defined stop rule is required before any expansion because entries expand quietly through successive blended-cohort pilots that keep promising breakeven once enrolment yield improves.
These three together are the signature. One on its own usually points somewhere else.
✓ The investment memo rests on projected enrolment numbers and market growth with no modelling of how completion rate or instructor utilisation would change.
✓ No document states the exact enrolment yield or ebitda threshold that would trigger exit.
✓ Current operations show flat revenue from the existing 5,760 enrolments and the new segment is presented as the route to 13.44 m USD.
The move that usually makes it worse. Committing capital to new cohorts because the core 11.52 m USD revenue line has stalled, which diverts attention from fixing enrolment yield and support costs in the business already running.
It is for you if you run or finance an education and training provider and the case rests mainly on market size and growth rate. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an education and training provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Brightsel Learning Group, a sample company profile used for testing rather than a customer — 11.52 m USD revenue from 5,760 enrolments.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Monetise the existing 48 contracts by adding regulatory add-ons delivered at the physical sites to lift ACV 25–30 % and protect margin.
| Investment required | 0.35–0.45 m USD (within the stated 0.85 m USD FY2026 cap) |
| Expected return | Base case incremental EBITDA of 0.45–0.55 m USD on 0.40 m USD investment yields 1.1–1.4× payback within 18 months; upside case reaches 1.8× if 5 new contracts are added by Month 24. |
| Revenue, year 1 | 12.4–12.7 m USD |
| Revenue, year 2 | 13.3–14.0 m USD |
| Revenue, year 3 | 14.5–15.5 m USD |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than 50 % of the 48 contracts have renewed at the 25 % premium OR if instructor utilisation falls below 65 % for two consecutive quarters, signalling demand or capacity failure. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Market Entry & Expansion Strategy, one of 29 engagements the platform runs. For education and training providers it works through 14.4 %, 71 %, 18.3 % and 312 USD, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
List what you already own that the new market values, and what a credible incumbent there owns that you do not. If the second list is longer and includes anything structural — distribution, regulation, data depth — entry is a build, not an extension.
Set the number before you start, and treat exceeding it as the kill criterion rather than as a reason to invest more. Most failed entries were never killed, only slowly starved.
Whichever reuses more of what you already have. Geography usually reuses the product and rebuilds distribution; a new segment usually reuses distribution and rebuilds the product. Whichever rebuild is smaller is the safer bet.
Materially, yes. To reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 14.4 %, 71 %, 18.3 %, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 14.4 % and 71 %. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית